ICD-10-CM/PCS MS-DRG v42.0 Definitions Manual
![Previous Page [Alt-p]](bakpg.png){kind=small}
![Up a level [Alt-u]](uptop.png){kind=small}
![Next Page [Alt-n]](fwdpg.png){kind=small}
ICD-10-CM/PCS MS-DRG v42.0 Definitions Manual |
||||
| Skip to content | |
|
|
| MDC 15 Newborns and other neonates with conditions originating in perinatal period |
| Full term neonate with major problems |
| Page 6 of 6 |
OR SECONDARY DIAGNOSIS (continued)
A35 D75821 I80253 M84434A S72012A T43025A
| T43025A | Adverse effect of tetracyclic antidepressants, initial encounter |
| T431X5A | Adverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter |
| T43205A | Adverse effect of unspecified antidepressants, initial encounter |
| T43215A | Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter |
| T43225A | Adverse effect of selective serotonin reuptake inhibitors, initial encounter |
| T43295A | Adverse effect of other antidepressants, initial encounter |
| T433X5A | Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter |
| T434X5A | Adverse effect of butyrophenone and thiothixene neuroleptics, initial encounter |
| T43505A | Adverse effect of unspecified antipsychotics and neuroleptics, initial encounter |
| T43595A | Adverse effect of other antipsychotics and neuroleptics, initial encounter |
| T43605A | Adverse effect of unspecified psychostimulants, initial encounter |
| T43615A | Adverse effect of caffeine, initial encounter |
| T43625A | Adverse effect of amphetamines, initial encounter |
| T43635A | Adverse effect of methylphenidate, initial encounter |
| T43655A | Adverse effect of methamphetamines, initial encounter |
| T43695A | Adverse effect of other psychostimulants, initial encounter |
| T438X5A | Adverse effect of other psychotropic drugs, initial encounter |
| T4395XA | Adverse effect of unspecified psychotropic drug, initial encounter |
| T440X5A | Adverse effect of anticholinesterase agents, initial encounter |
| T441X5A | Adverse effect of other parasympathomimetics [cholinergics], initial encounter |
| T442X5A | Adverse effect of ganglionic blocking drugs, initial encounter |
| T443X5A | Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter |
| T444X5A | Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter |
| T445X5A | Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter |
| T446X5A | Adverse effect of alpha-adrenoreceptor antagonists, initial encounter |
| T447X5A | Adverse effect of beta-adrenoreceptor antagonists, initial encounter |
| T448X5A | Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter |
| T44905A | Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter |
| T44995A | Adverse effect of other drug primarily affecting the autonomic nervous system, initial encounter |
| T450X5A | Adverse effect of antiallergic and antiemetic drugs, initial encounter |
| T451X5A | Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter |
| T452X5A | Adverse effect of vitamins, initial encounter |
| T453X5A | Adverse effect of enzymes, initial encounter |
| T454X5A | Adverse effect of iron and its compounds, initial encounter |
| T45515A | Adverse effect of anticoagulants, initial encounter |
| T45525A | Adverse effect of antithrombotic drugs, initial encounter |
| T45605A | Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter |
| T45615A | Adverse effect of thrombolytic drugs, initial encounter |
| T45625A | Adverse effect of hemostatic drug, initial encounter |
| T45695A | Adverse effect of other fibrinolysis-affecting drugs, initial encounter |
| T457X5A | Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter |
| T458X5A | Adverse effect of other primarily systemic and hematological agents, initial encounter |
| T4595XA | Adverse effect of unspecified primarily systemic and hematological agent, initial encounter |
| T45AX5A | Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, initial encounter |
| T460X5A | Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter |
| T461X5A | Adverse effect of calcium-channel blockers, initial encounter |
| T462X5A | Adverse effect of other antidysrhythmic drugs, initial encounter |
| T463X5A | Adverse effect of coronary vasodilators, initial encounter |
| T464X5A | Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter |
| T465X5A | Adverse effect of other antihypertensive drugs, initial encounter |
| T466X5A | Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter |
| T467X5A | Adverse effect of peripheral vasodilators, initial encounter |
| T468X5A | Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter |
| T46905A | Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter |
| T46995A | Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter |
| T470X5A | Adverse effect of histamine H2-receptor blockers, initial encounter |
| T471X5A | Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter |
| T472X5A | Adverse effect of stimulant laxatives, initial encounter |
| T473X5A | Adverse effect of saline and osmotic laxatives, initial encounter |
| T474X5A | Adverse effect of other laxatives, initial encounter |
| T475X5A | Adverse effect of digestants, initial encounter |
| T476X5A | Adverse effect of antidiarrheal drugs, initial encounter |
| T477X5A | Adverse effect of emetics, initial encounter |
| T478X5A | Adverse effect of other agents primarily affecting gastrointestinal system, initial encounter |
| T4795XA | Adverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter |
| T480X5A | Adverse effect of oxytocic drugs, initial encounter |
| T481X5A | Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter |
| T48205A | Adverse effect of unspecified drugs acting on muscles, initial encounter |
| T48295A | Adverse effect of other drugs acting on muscles, initial encounter |
| T483X5A | Adverse effect of antitussives, initial encounter |
| T484X5A | Adverse effect of expectorants, initial encounter |
| T485X5A | Adverse effect of other anti-common-cold drugs, initial encounter |
| T486X5A | Adverse effect of antiasthmatics, initial encounter |
| T48905A | Adverse effect of unspecified agents primarily acting on the respiratory system, initial encounter |
| T48995A | Adverse effect of other agents primarily acting on the respiratory system, initial encounter |
| T490X5A | Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter |
| T491X5A | Adverse effect of antipruritics, initial encounter |
| T492X5A | Adverse effect of local astringents and local detergents, initial encounter |
| T493X5A | Adverse effect of emollients, demulcents and protectants, initial encounter |
| T494X5A | Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter |
| T495X5A | Adverse effect of ophthalmological drugs and preparations, initial encounter |
| T496X5A | Adverse effect of otorhinolaryngological drugs and preparations, initial encounter |
| T497X5A | Adverse effect of dental drugs, topically applied, initial encounter |
| T498X5A | Adverse effect of other topical agents, initial encounter |
| T4995XA | Adverse effect of unspecified topical agent, initial encounter |
| T500X5A | Adverse effect of mineralocorticoids and their antagonists, initial encounter |
| T501X5A | Adverse effect of loop [high-ceiling] diuretics, initial encounter |
| T502X5A | Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter |
| T503X5A | Adverse effect of electrolytic, caloric and water-balance agents, initial encounter |
| T504X5A | Adverse effect of drugs affecting uric acid metabolism, initial encounter |
| T505X5A | Adverse effect of appetite depressants, initial encounter |
| T506X5A | Adverse effect of antidotes and chelating agents, initial encounter |
| T507X5A | Adverse effect of analeptics and opioid receptor antagonists, initial encounter |
| T508X5A | Adverse effect of diagnostic agents, initial encounter |
| T50905A | Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter |
| T50915A | Adverse effect of multiple unspecified drugs, medicaments and biological substances, initial encounter |
| T50995A | Adverse effect of other drugs, medicaments and biological substances, initial encounter |
| T50A15A | Adverse effect of pertussis vaccine, including combinations with a pertussis component, initial encounter |
| T50A25A | Adverse effect of mixed bacterial vaccines without a pertussis component, initial encounter |
| T50A95A | Adverse effect of other bacterial vaccines, initial encounter |
| T50B15A | Adverse effect of smallpox vaccines, initial encounter |
| T50B95A | Adverse effect of other viral vaccines, initial encounter |
| T50Z15A | Adverse effect of immunoglobulin, initial encounter |
| T50Z95A | Adverse effect of other vaccines and biological substances, initial encounter |
| T7841XA | Arthus phenomenon, initial encounter |
| T790XXA | Air embolism (traumatic), initial encounter |
| T791XXA | Fat embolism (traumatic), initial encounter |
| T792XXA | Traumatic secondary and recurrent hemorrhage and seroma, initial encounter |
| T794XXA | Traumatic shock, initial encounter |
| T795XXA | Traumatic anuria, initial encounter |
| T797XXA | Traumatic subcutaneous emphysema, initial encounter |
| T800XXA | Air embolism following infusion, transfusion and therapeutic injection, initial encounter |
| T801XXA | Vascular complications following infusion, transfusion and therapeutic injection, initial encounter |
| T8022XA | Acute infection following transfusion, infusion, or injection of blood and blood products, initial encounter |
| T8029XA | Infection following other infusion, transfusion and therapeutic injection, initial encounter |
| T8030XA | ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter |
| T80310A | ABO incompatibility with acute hemolytic transfusion reaction, initial encounter |
| T80311A | ABO incompatibility with delayed hemolytic transfusion reaction, initial encounter |
| T80319A | ABO incompatibility with hemolytic transfusion reaction, unspecified, initial encounter |
| T8039XA | Other ABO incompatibility reaction due to transfusion of blood or blood products, initial encounter |
| T8040XA | Rh incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter |
| T80410A | Rh incompatibility with acute hemolytic transfusion reaction, initial encounter |
| T80411A | Rh incompatibility with delayed hemolytic transfusion reaction, initial encounter |
| T80419A | Rh incompatibility with hemolytic transfusion reaction, unspecified, initial encounter |
| T8049XA | Other Rh incompatibility reaction due to transfusion of blood or blood products, initial encounter |
| T8051XA | Anaphylactic reaction due to administration of blood and blood products, initial encounter |
| T8052XA | Anaphylactic reaction due to vaccination, initial encounter |
| T8059XA | Anaphylactic reaction due to other serum, initial encounter |
| T8061XA | Other serum reaction due to administration of blood and blood products, initial encounter |
| T8062XA | Other serum reaction due to vaccination, initial encounter |
| T8069XA | Other serum reaction due to other serum, initial encounter |
| T80810A | Extravasation of vesicant antineoplastic chemotherapy, initial encounter |
| T80818A | Extravasation of other vesicant agent, initial encounter |
| T8082XA | Complication of immune effector cellular therapy, initial encounter |
| T8089XA | Other complications following infusion, transfusion and therapeutic injection, initial encounter |
| T8090XA | Unspecified complication following infusion and therapeutic injection, initial encounter |
| T80910A | Acute hemolytic transfusion reaction, unspecified incompatibility, initial encounter |
| T80911A | Delayed hemolytic transfusion reaction, unspecified incompatibility, initial encounter |
| T80919A | Hemolytic transfusion reaction, unspecified incompatibility, unspecified as acute or delayed, initial encounter |
| T8092XA | Unspecified transfusion reaction, initial encounter |
| T80A0XA | Non-ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter |
| T80A10A | Non-ABO incompatibility with acute hemolytic transfusion reaction, initial encounter |
| T80A11A | Non-ABO incompatibility with delayed hemolytic transfusion reaction, initial encounter |
| T80A19A | Non-ABO incompatibility with hemolytic transfusion reaction, unspecified, initial encounter |
| T80A9XA | Other non-ABO incompatibility reaction due to transfusion of blood or blood products, initial encounter |
| T8110XA | Postprocedural shock unspecified, initial encounter |
| T8111XA | Postprocedural cardiogenic shock, initial encounter |
| T8112XA | Postprocedural septic shock, initial encounter |
| T8119XA | Other postprocedural shock, initial encounter |
| T8140XA | Infection following a procedure, unspecified, initial encounter |
| T8141XA | Infection following a procedure, superficial incisional surgical site, initial encounter |
| T8142XA | Infection following a procedure, deep incisional surgical site, initial encounter |
| T8143XA | Infection following a procedure, organ and space surgical site, initial encounter |
| T8144XA | Sepsis following a procedure, initial encounter |
| T8149XA | Infection following a procedure, other surgical site, initial encounter |
| T81500A | Unspecified complication of foreign body accidentally left in body following surgical operation, initial encounter |
| T81501A | Unspecified complication of foreign body accidentally left in body following infusion or transfusion, initial encounter |
| T81502A | Unspecified complication of foreign body accidentally left in body following kidney dialysis, initial encounter |
| T81503A | Unspecified complication of foreign body accidentally left in body following injection or immunization, initial encounter |
| T81504A | Unspecified complication of foreign body accidentally left in body following endoscopic examination, initial encounter |
| T81505A | Unspecified complication of foreign body accidentally left in body following heart catheterization, initial encounter |
| T81506A | Unspecified complication of foreign body accidentally left in body following aspiration, puncture or other catheterization, initial encounter |
| T81507A | Unspecified complication of foreign body accidentally left in body following removal of catheter or packing, initial encounter |
| T81508A | Unspecified complication of foreign body accidentally left in body following other procedure, initial encounter |
| T81509A | Unspecified complication of foreign body accidentally left in body following unspecified procedure, initial encounter |
| T81510A | Adhesions due to foreign body accidentally left in body following surgical operation, initial encounter |
| T81511A | Adhesions due to foreign body accidentally left in body following infusion or transfusion, initial encounter |
| T81512A | Adhesions due to foreign body accidentally left in body following kidney dialysis, initial encounter |
| T81513A | Adhesions due to foreign body accidentally left in body following injection or immunization, initial encounter |
| T81514A | Adhesions due to foreign body accidentally left in body following endoscopic examination, initial encounter |
| T81515A | Adhesions due to foreign body accidentally left in body following heart catheterization, initial encounter |
| T81516A | Adhesions due to foreign body accidentally left in body following aspiration, puncture or other catheterization, initial encounter |
| T81517A | Adhesions due to foreign body accidentally left in body following removal of catheter or packing, initial encounter |
| T81518A | Adhesions due to foreign body accidentally left in body following other procedure, initial encounter |
| T81519A | Adhesions due to foreign body accidentally left in body following unspecified procedure, initial encounter |
| T81520A | Obstruction due to foreign body accidentally left in body following surgical operation, initial encounter |
| T81521A | Obstruction due to foreign body accidentally left in body following infusion or transfusion, initial encounter |
| T81522A | Obstruction due to foreign body accidentally left in body following kidney dialysis, initial encounter |
| T81523A | Obstruction due to foreign body accidentally left in body following injection or immunization, initial encounter |
| T81524A | Obstruction due to foreign body accidentally left in body following endoscopic examination, initial encounter |
| T81525A | Obstruction due to foreign body accidentally left in body following heart catheterization, initial encounter |
| T81526A | Obstruction due to foreign body accidentally left in body following aspiration, puncture or other catheterization, initial encounter |
| T81527A | Obstruction due to foreign body accidentally left in body following removal of catheter or packing, initial encounter |
| T81528A | Obstruction due to foreign body accidentally left in body following other procedure, initial encounter |
| T81529A | Obstruction due to foreign body accidentally left in body following unspecified procedure, initial encounter |
| T81530A | Perforation due to foreign body accidentally left in body following surgical operation, initial encounter |
| T81531A | Perforation due to foreign body accidentally left in body following infusion or transfusion, initial encounter |
| T81532A | Perforation due to foreign body accidentally left in body following kidney dialysis, initial encounter |
| T81533A | Perforation due to foreign body accidentally left in body following injection or immunization, initial encounter |
| T81534A | Perforation due to foreign body accidentally left in body following endoscopic examination, initial encounter |
| T81535A | Perforation due to foreign body accidentally left in body following heart catheterization, initial encounter |
| T81536A | Perforation due to foreign body accidentally left in body following aspiration, puncture or other catheterization, initial encounter |
| T81537A | Perforation due to foreign body accidentally left in body following removal of catheter or packing, initial encounter |
| T81538A | Perforation due to foreign body accidentally left in body following other procedure, initial encounter |
| T81539A | Perforation due to foreign body accidentally left in body following unspecified procedure, initial encounter |
| T81590A | Other complications of foreign body accidentally left in body following surgical operation, initial encounter |
| T81591A | Other complications of foreign body accidentally left in body following infusion or transfusion, initial encounter |
| T81592A | Other complications of foreign body accidentally left in body following kidney dialysis, initial encounter |
| T81593A | Other complications of foreign body accidentally left in body following injection or immunization, initial encounter |
| T81594A | Other complications of foreign body accidentally left in body following endoscopic examination, initial encounter |
| T81595A | Other complications of foreign body accidentally left in body following heart catheterization, initial encounter |
| T81596A | Other complications of foreign body accidentally left in body following aspiration, puncture or other catheterization, initial encounter |
| T81597A | Other complications of foreign body accidentally left in body following removal of catheter or packing, initial encounter |
| T81598A | Other complications of foreign body accidentally left in body following other procedure, initial encounter |
| T81599A | Other complications of foreign body accidentally left in body following unspecified procedure, initial encounter |
| T8160XA | Unspecified acute reaction to foreign substance accidentally left during a procedure, initial encounter |
| T8161XA | Aseptic peritonitis due to foreign substance accidentally left during a procedure, initial encounter |
| T8169XA | Other acute reaction to foreign substance accidentally left during a procedure, initial encounter |
| T81710A | Complication of mesenteric artery following a procedure, not elsewhere classified, initial encounter |
| T81711A | Complication of renal artery following a procedure, not elsewhere classified, initial encounter |
| T81718A | Complication of other artery following a procedure, not elsewhere classified, initial encounter |
| T81719A | Complication of unspecified artery following a procedure, not elsewhere classified, initial encounter |
| T8172XA | Complication of vein following a procedure, not elsewhere classified, initial encounter |
| T8183XA | Persistent postprocedural fistula, initial encounter |
| T819XXA | Unspecified complication of procedure, initial encounter |
| T880XXA | Infection following immunization, initial encounter |
| T882XXA | Shock due to anesthesia, initial encounter |
| T8853XA | Unintended awareness under general anesthesia during procedure, initial encounter |
| T8859XA | Other complications of anesthesia, initial encounter |
| U071 | COVID-19 |
|
Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244 29 Mar 2024 17:03:46 CMS, code-revision=361, description-revision=1397 |